All Stories

  1. Treatment of IgA nephropathy: a rapidly evolving field

    Article • Journal of the American Society of Nephrology, September 2023, Wolters Kluwer Health

    Dr Fernando Fervenza

  2. Maintenance of Remission and Risk of Relapse in Myeloperoxidase Positive Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Kidney Involvement

    Article • Clinical Journal of the American Society of Nephrology, December 2022, American Society of Nephrology

    Dr Fernando Fervenza

  3. Molecular Characterization of Membranous Nephropathy: Quo Vadis?

    Article • Journal of the American Society of Nephrology, May 2022, American Society of Nephrology

    Dr Fernando Fervenza

  4. Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy

    Article • Clinical Journal of the American Society of Nephrology, April 2021, American Society of Nephrology

    Dr Fernando Fervenza

  5. Use of anti-plasma cell antibody therapy in treatment of glomerular disease

    Article • Journal of the American Society of Nephrology, March 2021, American Society of Nephrology

    Dr Fernando Fervenza

  6. PEXIVAS

    Article • Clinical Journal of the American Society of Nephrology, September 2020, American Society of Nephrology

    Dr Fernando Fervenza

  7. Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach

    Article • Journal of the American Society of Nephrology, January 2018, American Society of Nephrology

    An De Vriese, Dr Fernando Fervenza

  8. Persistent Microscopic Hematuria as a Risk Factor for Progression of IgA Nephropathy: New Floodlight on a Nearly Forgotten Biomarker

    Article • Journal of the American Society of Nephrology, July 2017, American Society of Nephrology

    Dr Fernando Fervenza

  9. Baseline and early outcomes in glomerular disease patients

    Article • Clinical Journal of the American Society of Nephrology, December 2015, American Society of Nephrology

    MD richard lafayette, Katherine R Tuttle, Dr Fernando Fervenza, Dr Michelle Hladunewich, Dr Marva Moxey-Mims, Dr Alicia M Neu, Crystal A Gadegbeku, Dr Howard Trachtman, Dr Stephen M Hewitt, Jeffrey Kopp

  10. Circulating Complement Levels and C3 Glomerulopathy

    Article • Clinical Journal of the American Society of Nephrology, October 2014, American Society of Nephrology

    Dr Fernando Fervenza, Sanjeev Sethi

  11. American Society of Nephrology Quiz and Questionnaire 2013: Glomerulonephritis

    Article • Clinical Journal of the American Society of Nephrology, February 2014, American Society of Nephrology

    Dr Fernando Fervenza

  12. A Patient with Nephrotic-Range Proteinuria and Focal Global Glomerulosclerosis

    Article • Clinical Journal of the American Society of Nephrology, July 2013, American Society of Nephrology

    Dr Fernando Fervenza

  13. American Society of Nephrology Quiz and Questionnaire 2012: Glomerulonephritis

    Article • Clinical Journal of the American Society of Nephrology, March 2013, American Society of Nephrology

    Dr. Richard J. Glassock, Dr Fernando Fervenza, Dr Anthony J Bleyer

  14. Laser Microdissection and Proteomic Analysis of Amyloidosis, Cryoglobulinemic GN, Fibrillary GN, and Immunotactoid Glomerulopathy

    Article • Clinical Journal of the American Society of Nephrology, February 2013, American Society of Nephrology

    Dr Qi Qian, Dr Nelson Leung, Dr Fernando Fervenza, Sanjeev Sethi

  15. Urinary Albumin Excretion Patterns of Patients with Cast Nephropathy and Other Monoclonal Gammopathy-Related Kidney Diseases

    Article • Clinical Journal of the American Society of Nephrology, September 2012, American Society of Nephrology

    Shaji K Kumar, Dr Nelson Leung, Dr Fernando Fervenza, Sanjeev Sethi

  16. Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy

    Article • Clinical Journal of the American Society of Nephrology, July 2012, American Society of Nephrology

    Professor piergiorgio Messa, Dr Renato Alberto Sinico, dr antonella radice, Dr Fernando Fervenza, Gian Marco Ghiggeri

  17. Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease

    Article • Biologics Targets & Therapy, November 2008, Dove Medical Press

    Dr Fernando Fervenza, roser torra